The new retrospective population-based cohort study from the Mayo Clinic included data from 1993 patients with polyneuropathy.
Research suggests increasing synaptic activity could alleviate SMA symptoms: motor function of mice was improved when treated with a glutamate receptor stimulant.
In this edition of our new column, #NCintroduces, Tom Naughton (UCL Cancer Institute) introduces the complex world of chronobiology and circadian rhythms.
Dr Deer discusses his career highlights, most memorable patient cases, and looks ahead at future challenges and trends in the field of neuromodulation.
A scientific communication that attempts to understand the attitudes of Chinese medical students toward clinical neuroscience to provide a necessary step in curriculum development and reform in the neurosciences.
Live event: Wednesday 14th June 2017 07:00 [PDT] 10:00 [EDT] 15:00 [GMT]
Assessing how drugs affect the CNS is becoming an increasing concern, particularly for road safety. In January 2015, the FDA issued the Draft Guidance – Evaluating Drug Effects on the Ability to Operate a Motor Vehicle. 2 years later, where are we now?
This article evaluates the potential role of vascular dysfunction and chronic inflammation in both acute- and chronic-phase traumatic brain injury, and also features studies investigating biomarkers associated with poorer injury outcome.
Eric Wasserman discusses tells us more about his work, uses for noninvasive brain stimulation, and the potential for neuromodulation in the treatment of neurological disorders.
An evaluation of ‘IL4I1 augments CNS remyelination and axonal protection by modulating T-cell driven inflammation’, recently published in Brain.
The article reviews current literature on the use of adoptive immunotherapy for malignant gliomas as well as the
the concept of antitumor activity mediated by CIK cells.